Uncovering cancer’s secrets: could liquid biopsies and artificial intelligence hold the answers?

Our partnered journal Future Oncology has recently published an Editorial article exploring the potential of artificial intelligence and liquid biopsies have in achieving early cancer detection for all. Unlocking the potential of liquid biopsies The use of tools such as CRISPR has proved immensely useful in uncovering vulnerabilities in the genetic makeup of tumors [1]. Projects such as the Cancer Dependency Map, the Cancer Cell Line Encyclopedia, the Project Score database and the ENCyclopedia Of DNA Elements have pushed forward our understanding to highlight links between genetic variations and disease predisposition, paving the way for earlier diagnosis [2–5]. An increased understanding...